nodes	percent_of_prediction	percent_of_DWPC	metapath
Misoprostol—PTGER4—lymphoid tissue—acquired immunodeficiency syndrome	0.0115	0.0696	CbGeAlD
Misoprostol—PTGER4—digestive system—acquired immunodeficiency syndrome	0.0113	0.0688	CbGeAlD
Misoprostol—PTGER2—blood—acquired immunodeficiency syndrome	0.011	0.0667	CbGeAlD
Misoprostol—PTGER4—blood—acquired immunodeficiency syndrome	0.0108	0.0655	CbGeAlD
Misoprostol—PTGER2—bone marrow—acquired immunodeficiency syndrome	0.0106	0.0646	CbGeAlD
Misoprostol—PTGER2—vagina—acquired immunodeficiency syndrome	0.0102	0.0619	CbGeAlD
Misoprostol—PTGER2—lung—acquired immunodeficiency syndrome	0.00963	0.0585	CbGeAlD
Misoprostol—PTGER3—digestive system—acquired immunodeficiency syndrome	0.00959	0.0582	CbGeAlD
Misoprostol—PTGER4—lung—acquired immunodeficiency syndrome	0.00945	0.0574	CbGeAlD
Misoprostol—PTGER4—nervous system—acquired immunodeficiency syndrome	0.00875	0.0532	CbGeAlD
Misoprostol—PTGER4—central nervous system—acquired immunodeficiency syndrome	0.00843	0.0512	CbGeAlD
Misoprostol—PTGER3—lung—acquired immunodeficiency syndrome	0.00801	0.0486	CbGeAlD
Misoprostol—PTGER3—nervous system—acquired immunodeficiency syndrome	0.00741	0.045	CbGeAlD
Misoprostol—PTGER3—central nervous system—acquired immunodeficiency syndrome	0.00714	0.0434	CbGeAlD
Misoprostol—PTGER4—brain—acquired immunodeficiency syndrome	0.00669	0.0406	CbGeAlD
Misoprostol—PTGER2—lymph node—acquired immunodeficiency syndrome	0.00659	0.04	CbGeAlD
Misoprostol—PTGER4—lymph node—acquired immunodeficiency syndrome	0.00647	0.0393	CbGeAlD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00639	0.0318	CbGpPWpGaD
Misoprostol—PTGER3—brain—acquired immunodeficiency syndrome	0.00567	0.0344	CbGeAlD
Misoprostol—PTGER3—lymph node—acquired immunodeficiency syndrome	0.00548	0.0333	CbGeAlD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00525	0.0261	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00487	0.0242	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00484	0.0241	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.004	0.0199	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00387	0.0193	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00369	0.0184	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.0035	0.0174	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00318	0.0158	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00295	0.0147	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00293	0.0146	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00288	0.0143	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00267	0.0133	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00265	0.0132	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00253	0.0126	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.0025	0.0124	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00242	0.0121	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00239	0.0119	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00237	0.0118	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00223	0.0111	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00219	0.0109	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00216	0.0108	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00207	0.0103	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00206	0.0103	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00205	0.0102	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00203	0.0101	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00203	0.0101	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00202	0.0101	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00196	0.00978	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00195	0.00971	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00194	0.00965	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00194	0.00965	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00191	0.00953	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00189	0.00942	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00182	0.00907	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00181	0.00903	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.0018	0.00896	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00178	0.00885	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00167	0.00832	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00167	0.00832	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00165	0.0082	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00164	0.00816	CbGpPWpGaD
Misoprostol—PTGER4—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00163	0.0081	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00155	0.00771	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00155	0.00771	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00155	0.00771	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00154	0.00768	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00154	0.00768	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00151	0.00753	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.0015	0.00745	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00148	0.00735	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00147	0.00734	CbGpPWpGaD
Misoprostol—PTGER4—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00139	0.00694	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00138	0.00687	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00137	0.00681	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00135	0.00674	CbGpPWpGaD
Misoprostol—PTGER2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00134	0.00665	CbGpPWpGaD
Misoprostol—PTGER3—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00133	0.00662	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00127	0.00633	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00127	0.00633	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00127	0.00633	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00125	0.00622	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00124	0.00619	CbGpPWpGaD
Misoprostol—PTGER3—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00123	0.00614	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00121	0.00603	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00118	0.00587	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00117	0.00585	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00117	0.00585	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00117	0.00584	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00115	0.00571	CbGpPWpGaD
Misoprostol—PTGER2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00114	0.0057	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00112	0.0056	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00112	0.00557	CbGpPWpGaD
Misoprostol—PTGER4—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00106	0.00529	CbGpPWpGaD
Misoprostol—PTGER3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00106	0.00526	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00104	0.00516	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000968	0.00482	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000935	0.00465	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000931	0.00464	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000894	0.00445	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000894	0.00445	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000893	0.00445	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000875	0.00436	CbGpPWpGaD
Misoprostol—PTGER4—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000875	0.00436	CbGpPWpGaD
Misoprostol—PTGER2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000872	0.00434	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000845	0.00421	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000808	0.00403	CbGpPWpGaD
Misoprostol—PTGER3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000805	0.00401	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000795	0.00396	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000795	0.00396	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000768	0.00382	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000765	0.00381	CbGpPWpGaD
Misoprostol—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000743	0.00117	CcSEcCtD
Misoprostol—Chills—Lamivudine—acquired immunodeficiency syndrome	0.000741	0.00117	CcSEcCtD
Misoprostol—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000739	0.00117	CcSEcCtD
Misoprostol—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000737	0.00116	CcSEcCtD
Misoprostol—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000737	0.00116	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000734	0.00366	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000734	0.00366	CbGpPWpGaD
Misoprostol—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000733	0.00116	CcSEcCtD
Misoprostol—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000731	0.00115	CcSEcCtD
Misoprostol—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000731	0.00115	CcSEcCtD
Misoprostol—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.00073	0.00115	CcSEcCtD
Misoprostol—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000729	0.00115	CcSEcCtD
Misoprostol—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000729	0.00115	CcSEcCtD
Misoprostol—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000725	0.00114	CcSEcCtD
Misoprostol—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000724	0.00114	CcSEcCtD
Misoprostol—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000724	0.00114	CcSEcCtD
Misoprostol—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000722	0.00114	CcSEcCtD
Misoprostol—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000721	0.00114	CcSEcCtD
Misoprostol—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000721	0.00114	CcSEcCtD
Misoprostol—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000721	0.00114	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000719	0.00358	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000719	0.00358	CbGpPWpGaD
Misoprostol—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000719	0.00113	CcSEcCtD
Misoprostol—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000711	0.00112	CcSEcCtD
Misoprostol—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00071	0.00112	CcSEcCtD
Misoprostol—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000709	0.00112	CcSEcCtD
Misoprostol—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000709	0.00112	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000709	0.00353	CbGpPWpGaD
Misoprostol—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000707	0.00112	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000706	0.00351	CbGpPWpGaD
Misoprostol—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000703	0.00111	CcSEcCtD
Misoprostol—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000703	0.00111	CcSEcCtD
Misoprostol—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000703	0.00111	CcSEcCtD
Misoprostol—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000703	0.00111	CcSEcCtD
Misoprostol—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000699	0.0011	CcSEcCtD
Misoprostol—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000699	0.0011	CcSEcCtD
Misoprostol—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000697	0.0011	CcSEcCtD
Misoprostol—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000697	0.0011	CcSEcCtD
Misoprostol—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000697	0.0011	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000697	0.0011	CcSEcCtD
Misoprostol—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000696	0.0011	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000694	0.00346	CbGpPWpGaD
Misoprostol—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000693	0.00109	CcSEcCtD
Misoprostol—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.000692	0.00109	CcSEcCtD
Misoprostol—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000691	0.00109	CcSEcCtD
Misoprostol—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000689	0.00109	CcSEcCtD
Misoprostol—Rash—Didanosine—acquired immunodeficiency syndrome	0.000687	0.00108	CcSEcCtD
Misoprostol—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000687	0.00108	CcSEcCtD
Misoprostol—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000687	0.00108	CcSEcCtD
Misoprostol—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000687	0.00108	CcSEcCtD
Misoprostol—Headache—Didanosine—acquired immunodeficiency syndrome	0.000683	0.00108	CcSEcCtD
Misoprostol—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000682	0.00107	CcSEcCtD
Misoprostol—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000681	0.00107	CcSEcCtD
Misoprostol—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00068	0.00107	CcSEcCtD
Misoprostol—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00068	0.00107	CcSEcCtD
Misoprostol—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000679	0.00107	CcSEcCtD
Misoprostol—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000678	0.00107	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000677	0.00337	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000677	0.00337	CbGpPWpGaD
Misoprostol—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000677	0.00107	CcSEcCtD
Misoprostol—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000676	0.00107	CcSEcCtD
Misoprostol—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000676	0.00107	CcSEcCtD
Misoprostol—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000673	0.00106	CcSEcCtD
Misoprostol—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000672	0.00106	CcSEcCtD
Misoprostol—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00067	0.00106	CcSEcCtD
Misoprostol—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000669	0.00105	CcSEcCtD
Misoprostol—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000668	0.00105	CcSEcCtD
Misoprostol—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000667	0.00105	CcSEcCtD
Misoprostol—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000667	0.00105	CcSEcCtD
Misoprostol—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000667	0.00105	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000666	0.00332	CbGpPWpGaD
Misoprostol—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000665	0.00105	CcSEcCtD
Misoprostol—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000665	0.00105	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000664	0.00331	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000663	0.0033	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000663	0.0033	CbGpPWpGaD
Misoprostol—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000663	0.00104	CcSEcCtD
Misoprostol—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000659	0.00104	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000658	0.00104	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000656	0.00327	CbGpPWpGaD
Misoprostol—Pain—Indinavir—acquired immunodeficiency syndrome	0.000654	0.00103	CcSEcCtD
Misoprostol—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000654	0.00103	CcSEcCtD
Misoprostol—PTGER2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000653	0.00325	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000653	0.00325	CbGpPWpGaD
Misoprostol—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000651	0.00103	CcSEcCtD
Misoprostol—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00065	0.00102	CcSEcCtD
Misoprostol—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00065	0.00102	CcSEcCtD
Misoprostol—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000649	0.00102	CcSEcCtD
Misoprostol—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000647	0.00102	CcSEcCtD
Misoprostol—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000647	0.00102	CcSEcCtD
Misoprostol—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000646	0.00102	CcSEcCtD
Misoprostol—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000645	0.00102	CcSEcCtD
Misoprostol—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000645	0.00102	CcSEcCtD
Misoprostol—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000644	0.00102	CcSEcCtD
Misoprostol—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000642	0.00101	CcSEcCtD
Misoprostol—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000642	0.00101	CcSEcCtD
Misoprostol—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000642	0.00101	CcSEcCtD
Misoprostol—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000642	0.00101	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000641	0.00319	CbGpPWpGaD
Misoprostol—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00064	0.00101	CcSEcCtD
Misoprostol—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000639	0.00101	CcSEcCtD
Misoprostol—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000638	0.00101	CcSEcCtD
Misoprostol—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000636	0.001	CcSEcCtD
Misoprostol—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000632	0.000996	CcSEcCtD
Misoprostol—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00063	0.000993	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00063	0.000993	CcSEcCtD
Misoprostol—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000629	0.000991	CcSEcCtD
Misoprostol—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000628	0.000989	CcSEcCtD
Misoprostol—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000626	0.000987	CcSEcCtD
Misoprostol—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000626	0.000986	CcSEcCtD
Misoprostol—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000625	0.000986	CcSEcCtD
Misoprostol—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000623	0.000982	CcSEcCtD
Misoprostol—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000623	0.000982	CcSEcCtD
Misoprostol—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.00062	0.000978	CcSEcCtD
Misoprostol—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000618	0.000974	CcSEcCtD
Misoprostol—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000618	0.000974	CcSEcCtD
Misoprostol—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000618	0.000974	CcSEcCtD
Misoprostol—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000618	0.000974	CcSEcCtD
Misoprostol—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000617	0.000973	CcSEcCtD
Misoprostol—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000616	0.000971	CcSEcCtD
Misoprostol—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000616	0.000971	CcSEcCtD
Misoprostol—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000615	0.00097	CcSEcCtD
Misoprostol—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000615	0.000969	CcSEcCtD
Misoprostol—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000614	0.000967	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000613	0.00305	CbGpPWpGaD
Misoprostol—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000612	0.000965	CcSEcCtD
Misoprostol—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000612	0.000965	CcSEcCtD
Misoprostol—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000612	0.000965	CcSEcCtD
Misoprostol—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000611	0.000963	CcSEcCtD
Misoprostol—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00061	0.000962	CcSEcCtD
Misoprostol—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000609	0.000959	CcSEcCtD
Misoprostol—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000605	0.000954	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000605	0.00301	CbGpPWpGaD
Misoprostol—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000605	0.000953	CcSEcCtD
Misoprostol—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000605	0.000953	CcSEcCtD
Misoprostol—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000603	0.000951	CcSEcCtD
Misoprostol—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000603	0.00095	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000602	0.003	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000602	0.003	CbGpPWpGaD
Misoprostol—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000602	0.000948	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.0006	0.00299	CbGpPWpGaD
Misoprostol—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000598	0.000943	CcSEcCtD
Misoprostol—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000598	0.000942	CcSEcCtD
Misoprostol—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000597	0.000942	CcSEcCtD
Misoprostol—Rash—Stavudine—acquired immunodeficiency syndrome	0.000597	0.00094	CcSEcCtD
Misoprostol—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000596	0.000939	CcSEcCtD
Misoprostol—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000596	0.000939	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000596	0.00297	CbGpPWpGaD
Misoprostol—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000595	0.000938	CcSEcCtD
Misoprostol—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000595	0.000938	CcSEcCtD
Misoprostol—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000595	0.000937	CcSEcCtD
Misoprostol—Headache—Stavudine—acquired immunodeficiency syndrome	0.000593	0.000934	CcSEcCtD
Misoprostol—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000593	0.000934	CcSEcCtD
Misoprostol—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000592	0.000933	CcSEcCtD
Misoprostol—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000591	0.000932	CcSEcCtD
Misoprostol—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000591	0.000932	CcSEcCtD
Misoprostol—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000591	0.000931	CcSEcCtD
Misoprostol—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00059	0.00093	CcSEcCtD
Misoprostol—Rash—Abacavir—acquired immunodeficiency syndrome	0.000588	0.000926	CcSEcCtD
Misoprostol—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000587	0.000925	CcSEcCtD
Misoprostol—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000587	0.000925	CcSEcCtD
Misoprostol—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000587	0.000925	CcSEcCtD
Misoprostol—Headache—Abacavir—acquired immunodeficiency syndrome	0.000584	0.00092	CcSEcCtD
Misoprostol—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000583	0.000919	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000582	0.000918	CcSEcCtD
Misoprostol—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000582	0.000917	CcSEcCtD
Misoprostol—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000578	0.00091	CcSEcCtD
Misoprostol—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000575	0.000906	CcSEcCtD
Misoprostol—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000575	0.000906	CcSEcCtD
Misoprostol—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000571	0.0009	CcSEcCtD
Misoprostol—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000571	0.0009	CcSEcCtD
Misoprostol—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00057	0.000898	CcSEcCtD
Misoprostol—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00057	0.000898	CcSEcCtD
Misoprostol—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000568	0.000896	CcSEcCtD
Misoprostol—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000568	0.000894	CcSEcCtD
Misoprostol—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000565	0.000891	CcSEcCtD
Misoprostol—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000564	0.000888	CcSEcCtD
Misoprostol—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000563	0.000888	CcSEcCtD
Misoprostol—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000563	0.000887	CcSEcCtD
Misoprostol—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000563	0.000887	CcSEcCtD
Misoprostol—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000562	0.000886	CcSEcCtD
Misoprostol—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000561	0.000884	CcSEcCtD
Misoprostol—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000554	0.000873	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000552	0.00275	CbGpPWpGaD
Misoprostol—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000551	0.000869	CcSEcCtD
Misoprostol—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000549	0.000865	CcSEcCtD
Misoprostol—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000549	0.000865	CcSEcCtD
Misoprostol—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000549	0.000865	CcSEcCtD
Misoprostol—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000547	0.000862	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000547	0.00272	CbGpPWpGaD
Misoprostol—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000547	0.000862	CcSEcCtD
Misoprostol—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000547	0.000862	CcSEcCtD
Misoprostol—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000547	0.000861	CcSEcCtD
Misoprostol—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000547	0.000861	CcSEcCtD
Misoprostol—PTGER4—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000545	0.00271	CbGpPWpGaD
Misoprostol—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000544	0.000857	CcSEcCtD
Misoprostol—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000542	0.000854	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000539	0.00268	CbGpPWpGaD
Misoprostol—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000535	0.000843	CcSEcCtD
Misoprostol—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000532	0.000839	CcSEcCtD
Misoprostol—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000531	0.000836	CcSEcCtD
Misoprostol—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000527	0.00083	CcSEcCtD
Misoprostol—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000526	0.000829	CcSEcCtD
Misoprostol—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000526	0.000829	CcSEcCtD
Misoprostol—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000523	0.000825	CcSEcCtD
Misoprostol—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000523	0.000825	CcSEcCtD
Misoprostol—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000523	0.000824	CcSEcCtD
Misoprostol—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000523	0.000824	CcSEcCtD
Misoprostol—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000522	0.000822	CcSEcCtD
Misoprostol—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000519	0.000817	CcSEcCtD
Misoprostol—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000518	0.000817	CcSEcCtD
Misoprostol—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000518	0.000816	CcSEcCtD
Misoprostol—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000517	0.000814	CcSEcCtD
Misoprostol—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000515	0.000812	CcSEcCtD
Misoprostol—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000509	0.000803	CcSEcCtD
Misoprostol—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000507	0.000799	CcSEcCtD
Misoprostol—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000506	0.000798	CcSEcCtD
Misoprostol—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000506	0.000797	CcSEcCtD
Misoprostol—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000505	0.000797	CcSEcCtD
Misoprostol—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000505	0.000797	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000505	0.00251	CbGpPWpGaD
Misoprostol—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000503	0.000793	CcSEcCtD
Misoprostol—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000502	0.000791	CcSEcCtD
Misoprostol—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000502	0.000791	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000499	0.00249	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000497	0.00248	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000497	0.00247	CbGpPWpGaD
Misoprostol—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000496	0.000782	CcSEcCtD
Misoprostol—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000494	0.000779	CcSEcCtD
Misoprostol—PTGER2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000493	0.00245	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000489	0.00244	CbGpPWpGaD
Misoprostol—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000488	0.00077	CcSEcCtD
Misoprostol—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000486	0.000767	CcSEcCtD
Misoprostol—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000486	0.000767	CcSEcCtD
Misoprostol—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000486	0.000766	CcSEcCtD
Misoprostol—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000484	0.000762	CcSEcCtD
Misoprostol—Rash—Indinavir—acquired immunodeficiency syndrome	0.000482	0.00076	CcSEcCtD
Misoprostol—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000482	0.000759	CcSEcCtD
Misoprostol—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00048	0.000757	CcSEcCtD
Misoprostol—Headache—Indinavir—acquired immunodeficiency syndrome	0.000479	0.000755	CcSEcCtD
Misoprostol—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000478	0.000753	CcSEcCtD
Misoprostol—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000473	0.000746	CcSEcCtD
Misoprostol—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000471	0.000742	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00047	0.00234	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00047	0.00234	CbGpPWpGaD
Misoprostol—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000464	0.000731	CcSEcCtD
Misoprostol—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000464	0.000731	CcSEcCtD
Misoprostol—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000459	0.000724	CcSEcCtD
Misoprostol—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000459	0.000723	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000458	0.00228	CbGpPWpGaD
Misoprostol—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000457	0.000721	CcSEcCtD
Misoprostol—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000456	0.000718	CcSEcCtD
Misoprostol—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000455	0.000717	CcSEcCtD
Misoprostol—PTGER3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000455	0.00226	CbGpPWpGaD
Misoprostol—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000454	0.000716	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000454	0.00226	CbGpPWpGaD
Misoprostol—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000453	0.000715	CcSEcCtD
Misoprostol—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000453	0.000713	CcSEcCtD
Misoprostol—PTGER3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000451	0.00225	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000447	0.00223	CbGpPWpGaD
Misoprostol—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000442	0.000696	CcSEcCtD
Misoprostol—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00044	0.000693	CcSEcCtD
Misoprostol—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000437	0.000689	CcSEcCtD
Misoprostol—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000436	0.000687	CcSEcCtD
Misoprostol—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000436	0.000686	CcSEcCtD
Misoprostol—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000433	0.000683	CcSEcCtD
Misoprostol—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000433	0.000682	CcSEcCtD
Misoprostol—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000429	0.000676	CcSEcCtD
Misoprostol—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000423	0.000666	CcSEcCtD
Misoprostol—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000421	0.000664	CcSEcCtD
Misoprostol—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000421	0.000664	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000419	0.00208	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000413	0.00206	CbGpPWpGaD
Misoprostol—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000411	0.000647	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00041	0.00204	CbGpPWpGaD
Misoprostol—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000407	0.000641	CcSEcCtD
Misoprostol—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000407	0.000641	CcSEcCtD
Misoprostol—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000403	0.000635	CcSEcCtD
Misoprostol—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000403	0.000635	CcSEcCtD
Misoprostol—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000402	0.000633	CcSEcCtD
Misoprostol—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000401	0.000631	CcSEcCtD
Misoprostol—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000391	0.000617	CcSEcCtD
Misoprostol—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000388	0.000612	CcSEcCtD
Misoprostol—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000388	0.000611	CcSEcCtD
Misoprostol—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000388	0.000611	CcSEcCtD
Misoprostol—PTGER2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000386	0.00192	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000386	0.00192	CbGpPWpGaD
Misoprostol—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000386	0.000608	CcSEcCtD
Misoprostol—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00038	0.000599	CcSEcCtD
Misoprostol—PTGER3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000379	0.00188	CbGpPWpGaD
Misoprostol—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000373	0.000588	CcSEcCtD
Misoprostol—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00037	0.000583	CcSEcCtD
Misoprostol—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00037	0.000583	CcSEcCtD
Misoprostol—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000368	0.00058	CcSEcCtD
Misoprostol—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000366	0.000576	CcSEcCtD
Misoprostol—PTGER4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000357	0.00178	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000356	0.00177	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000356	0.00177	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000352	0.00175	CbGpPWpGaD
Misoprostol—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000349	0.00055	CcSEcCtD
Misoprostol—PTGER4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000347	0.00173	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000322	0.0016	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000315	0.00157	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000293	0.00146	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000289	0.00144	CbGpPWpGaD
Misoprostol—PTGER2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000285	0.00142	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000271	0.00135	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000267	0.00133	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000264	0.00132	CbGpPWpGaD
Misoprostol—PTGER3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000263	0.00131	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000259	0.00129	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000244	0.00121	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000239	0.00119	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000186	0.000926	CbGpPWpGaD
Misoprostol—PTGER4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000185	0.000921	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000153	0.00076	CbGpPWpGaD
Misoprostol—PTGER2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000152	0.000757	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000141	0.000702	CbGpPWpGaD
Misoprostol—PTGER3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.00014	0.000698	CbGpPWpGaD
Misoprostol—PTGER4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000109	0.000544	CbGpPWpGaD
Misoprostol—PTGER2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.98e-05	0.000447	CbGpPWpGaD
Misoprostol—PTGER3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.28e-05	0.000412	CbGpPWpGaD
